Eltrombopag: Investigation of Previously Reported Serum Discoloration and Negative Interference on a Total Bilirubin Diazo Method

Arch Pathol Lab Med. 2016 May;140(5):391-2. doi: 10.5858/arpa.2015-0473-LE.
No abstract available

MeSH terms

  • Adult
  • Azo Compounds / chemistry
  • Benzoates / adverse effects*
  • Benzoates / blood
  • Benzoates / chemistry
  • Benzoates / therapeutic use
  • Bilirubin / blood*
  • Color
  • Coloring Agents / chemistry
  • Diagnosis, Differential
  • Hematinics / adverse effects*
  • Hematinics / blood
  • Hematinics / chemistry
  • Hematinics / therapeutic use
  • Humans
  • Hydrazines / adverse effects*
  • Hydrazines / blood
  • Hydrazines / chemistry
  • Hydrazines / therapeutic use
  • Hyperbilirubinemia / blood
  • Hyperbilirubinemia / diagnosis
  • Hyperbilirubinemia / etiology
  • Leukemia, Myeloid, Acute / blood
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / physiopathology
  • Osmolar Concentration
  • Pyrazoles / adverse effects*
  • Pyrazoles / blood
  • Pyrazoles / chemistry
  • Pyrazoles / therapeutic use
  • Receptors, Thrombopoietin / agonists*
  • Receptors, Thrombopoietin / metabolism
  • Reproducibility of Results
  • Serum / chemistry
  • Spectrophotometry
  • Thrombocytopenia / diagnosis
  • Thrombocytopenia / etiology
  • Thrombocytopenia / prevention & control

Substances

  • Azo Compounds
  • Benzoates
  • Coloring Agents
  • Hematinics
  • Hydrazines
  • Pyrazoles
  • Receptors, Thrombopoietin
  • Bilirubin
  • eltrombopag